Home › NDC Lookup › RxCUI directory › RxCUI 1660009

Thiotepa 15 MG Injection — RxCUI 1660009

Name: Thiotepa 15 MG Injection (RxCUI 1660009)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1660009 Semantic clinical drug · SCD ● Current RxNorm concept 14 FDA products 14 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1660009

Official nameThiotepa 15 MG Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asTSPA 15 MG Injection

FDA products mapped14

Package NDCs mapped14

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Thiotepa Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Thiotepa is a chemotherapy drug used for a few different conditions. It treats certain breast and ovarian cancers, helps control cancer-related fluid buildup in body cavities, and...
No, thiotepa is never taken at home. It's always given by a trained healthcare team in a hospital or clinic. Depending on what it's treating, it may be infused into a vein (intrave...
How will I receive thiotepa — do I take it at home?
Some side effects are very common — especially low blood counts, which can make you feel tired and more prone to infection. You may also experience mouth sores, nausea, diarrhea, a...

📖 Read our full Thiotepa Injection guide →

🕸️ Concept Web — How Thiotepa 15 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Thiotepa 15 MG Injection RxCUI 1660009 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Thiotepa 10473 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Tepadina 1366537 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Thiotepa Injection 1660003 SCDF
- Thiotepa Injectable Product 1156487 SCDG
- Thiotepa Injection [Tepadina] 1919207 SBDF
- Tepadina Injectable Product 1919208 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Thiotepa 15 MG 1660008 SCDC
- Thiotepa 15 MG Injection [Tepadina] 1919211 SBD
- Thiotepa 15 MG [Tepadina] 1919210 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Thiotepa 15 MG SCDC · 1660008
Thiotepa Injection SCDF · 1660003
Thiotepa Injectable Product SCDG · 1156487

Brand-Name Concepts

Thiotepa 15 MG Injection [Tepadina] SBD · 1919211
Thiotepa 15 MG [Tepadina] SBDC · 1919210
Thiotepa Injection [Tepadina] SBDF · 1919207
Tepadina Injectable Product SBDG · 1919208
Tepadina BN · 1366537

📦 FDA Products & Package NDCs

14 products · 14 package NDCs

14 package NDCs map to RxCUI 1660009 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00143-9309-01	1 VIAL in 1 BOX, UNIT-DOSE (0143-9309-01) / 1.5 mL in 1 VIA...	Thiotepa	Hikma Pharmaceuticals USA Inc.	2001-06-01
00143-9565-01	1 VIAL in 1 BOX, UNIT-DOSE (0143-9565-01) / 1.5 mL in 1 VIA...	Thiotepa	Hikma Pharmaceuticals USA Inc.	2001-06-01
25021-0246-02	1 VIAL in 1 CARTON (25021-246-02) / 1.5 mL in 1 VIAL	Thiotepa	Sagent Pharmaceuticals	2018-06-15
43598-0650-11	1 VIAL in 1 CARTON (43598-650-11) / 1 INJECTION, POWDER, LY...	Thiotepa	Dr.Reddy's Laboratories Inc.,	2018-05-04
68083-0446-01	1 VIAL in 1 CARTON (68083-446-01) / 1 INJECTION, POWDER, LY...	Thiotepa	Gland Pharma Limited	2021-03-08
68083-0503-01	1 VIAL in 1 CARTON (68083-503-01) / 1 INJECTION, POWDER, LY...	Thiotepa	Gland Pharma Limited	2022-01-03
70121-1630-01	1 VIAL, GLASS in 1 BOX (70121-1630-1) / 1 INJECTION, POWDER...	TEPADINA	Amneal Pharmaceuticals LLC	2017-08-15
70121-1631-01	1 VIAL, GLASS in 1 BOX (70121-1631-1) / 1 INJECTION, POWDER...	TEPADINA	Amneal Pharmaceuticals LLC	2017-08-15
70121-1687-01	1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 BOX (701...	TEPADINA	Amneal Pharmaceuticals LLC	2025-04-18
70121-2749-01	1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 BOX (701...	TEPADINA	Amneal Pharmaceuticals LLC	2025-04-18
71288-0156-05	1 VIAL, SINGLE-DOSE in 1 CARTON (71288-156-05) / 1 INJECTIO...	Thiotepa	Meitheal Pharmaceuticals Inc	2023-12-26
71288-0157-10	1 VIAL, SINGLE-DOSE in 1 CARTON (71288-157-10) / 1 INJECTIO...	Thiotepa	Meitheal Pharmaceuticals Inc	2023-12-26
72205-0045-01	1 VIAL, GLASS in 1 BOX (72205-045-01) / 1 INJECTION, POWDER...	Thiotepa	Novadoz Pharmaceuticals LLC	2020-02-01
72205-0046-01	1 VIAL, GLASS in 1 BOX (72205-046-01) / 1 INJECTION, POWDER...	Thiotepa	Novadoz Pharmaceuticals LLC	2020-02-01

Observed labelers: Amneal Pharmaceuticals LLC (4) · Gland Pharma Limited (2) · Hikma Pharmaceuticals USA Inc. (2) · Meitheal Pharmaceuticals Inc (2) · Novadoz Pharmaceuticals LLC (2) · Dr.Reddy's Laboratories Inc., (1) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J9342	Inj thiotepa nos 1 mg	11	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.